Vitalhub Corp
OTC:VHIBF

Watchlist Manager
Vitalhub Corp Logo
Vitalhub Corp
OTC:VHIBF
Watchlist
Price: 5.959 USD 4.54% Market Closed
Market Cap: $302.4m

Vitalhub Corp
Investor Relations

VitalHub Corp develops mobile healthcare solutions that allow clinicians to access the information about patients. The company is headquartered in Toronto, Ontario. The company went IPO on 2015-07-03. The firm provides technology to health and human services providers including Hospitals, Regional Health Authorities, Mental Health, Long Term Care, Home Health, Community and Social Services. The firm products include Electronic Health Record (EHR), Case Management, Care Coordination, Patient Flow & Operational Visibility, and DOCit Mobile Apps. The company serves clients across Canada, United States of America, United Kingdom, Australia, Qatar, and Latvia. Its technologies include Blockchain, Mobile, and Web-Based Assessment, Client Management and Electronic Health Record (EHR) solutions. The company offers EHR, Case Management & Care Coordination Solutions to inpatient/outpatient care providers and community and social services focused organizations. Its Patient Flow & Operational Visibility Solutions are designed specifically for hospital and integrated health environments.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2025
Call Date
Nov 7, 2025
AI Summary
Q3 2025

Revenue Surge: VitalHub’s total revenue hit $32 million, up 94% year-over-year, with recurring revenue making up 74% of the total.

ARR Momentum: Annual recurring revenue (ARR) reached $93.7 million, up 15% organically and 75% including acquisitions and foreign exchange, just shy of the $100 million milestone.

Acquisition Impact: Two recent acquisitions now represent 30% of revenue, with integration and cost reduction initiatives underway and expected to impact results further in 2026.

Margin Focus: Gross margin held steady at 81%; adjusted EBITDA was $7.2 million (22% margin), down from 28% margin last year, reflecting acquisition integration.

Cash Position: The company ended the quarter with $123.8 million in cash and no debt, providing flexibility for more acquisitions.

Product Dynamics: SHREWD faces temporary headwinds in the NHS due to structural changes, but management expects other products, like Novari and Zesty, to pick up slack in the near term.

AI Initiatives: Multiple AI features are in development, with a focus on add-ons to existing products and an eye toward monetization in 2026 and beyond.

Guidance & Outlook: Management expects cost synergies and growth from recent acquisitions to drive margins back to the 26–28% range by late 2025 or early 2026.

Key Financials
Annual Recurring Revenue
$93.7 million
Total Revenue
$32 million
Recurring Revenue
$23.6 million
Virtual Care Term License Revenue
$2.5 million
Perpetual License Revenue
$500,000
Services, Hardware and Other Revenue
$5.5 million
Gross Margin
81%
Adjusted EBITDA
$7.2 million
Cash Balance
$123.8 million
Earnings Call Recording
Other Earnings Calls

Management

Mr. Daniel Matlow
President, CEO & Director
No Bio Available
Mr. Brian Goffenberg C.A., CPA, CA
CFO & Executive VP
No Bio Available
Mr. Patrick Mazza
Chief Operating Officer
No Bio Available
Ms. Lisa Riley
Deputy CEO and VP of Strategy & Sales
No Bio Available
Mr. Mike Sanders
CEO of VitalHub UK
No Bio Available
Graham Farrell
Investor Relations Officer
No Bio Available
Mr. Niels Tofting
Executive VP & MD of North American Operations
No Bio Available
Mr. Robert Lazar
Executive VP of Professional Services & Customer Care
No Bio Available
Mr. Vijit Coomara
Executive Vice President of Product Development
No Bio Available

Contacts

Address
ONTARIO
TORONTO
480 University Avenue, Suite 1001
Contacts
+16479654721.0
vitalhub.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett